Group One Trading’s Evogene EVGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,780
Closed -$23K 7466
2022
Q3
$23K Buy
2,780
+560
+25% +$5.4K ﹤0.01% 5966
2022
Q2
$17K Sell
2,220
-5,170
-70% -$50.5K ﹤0.01% 6403
2022
Q1
$96K Buy
7,390
+2,220
+43% +$29.9K ﹤0.01% 5525
2021
Q4
$85K Buy
5,170
+4,610
+823% +$105K ﹤0.01% 5871
2021
Q3
$15K Sell
560
-2,220
-80% -$64.8K ﹤0.01% 7314
2021
Q2
$95K Sell
2,780
-990
-26% -$38.8K ﹤0.01% 6017
2021
Q1
$190K Buy
+3,770
New +$233K ﹤0.01% 5080

Other funds holding EVGN

Group One Trading's EVGN Position: Q2 2024 in Review

Group One Trading sold out of Evogene (EVGN) in Q2 2024, closing a stake of 13 shares — an estimated $93 sold.

Group One Trading first reported a position in EVGN in Q1 2021 and held it in 11 quarters. The position peaked at $56K in Q1 2022. 28 funds tracked by Wall St. Rank hold EVGN as of Q2 2024.

  • Group One Trading reported no remaining Evogene position as of Q2 2024 after selling out during the quarter.
  • Group One Trading sold 13 Evogene shares in Q2 2024, an estimated $93.
  • Group One Trading first reported a position in Evogene in Q1 2021 and held it in 11 quarters.
  • Group One Trading's Evogene position peaked at $56K in Q1 2022.
  • 28 funds tracked by Wall St. Rank held Evogene as of Q2 2024.

Based on Group One Trading's 13F filing for Q2 2024, filed 14 Aug 2024.